Press

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

May 23 • 3 min read

Clearmind Medicine Inc. (Nasdaq, CSE: CMND / FSE: CWY), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the selection of its first U.S. site for the company’s Phase I/IIa clinical trial of its proprietary MEAI-based CMND-100 compound for the treatment of alcohol use…

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

May 23 • 3 min read

Clearmind Medicine Inc. (NASDAQ: CMND / CSE: CMND / FSE: CWY), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance…

MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)

May 19 • 2 min read

Mind Medicine (MindMed) Inc (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that the company’s Phase 2b study evaluating MM-120 (lysergide D-tartrate) for GAD is over 50% enrolled and dosed. The trial plans to enroll up to 200 participants who will receive a…

Revitalist Fails to Make Interest Payment on Promissory Note

May 19 • 2 min read

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM / OTCQB: RVLWF / FSE: 4DO), announces that it failed to remit an interest payment to the holder of an unsecured convertible promissory note dated April 19, 2022. The principal amount of the Note, being $250,000, bears simple interest at a rate of 8% per annum, and the…

Have a Good Trip Benefit Show to Celebrate MAPS and Psychedelic Medicine

May 19 • 4 min read

The Multidisciplinary Association for Psychedelic Studies (“MAPS”) today announced Good Trip Studios and AEG Presents Rocky Mountains are hosting Have a Good Trip, a benefit show for MAPS at the Mission Ballroom in Denver on June 22. This once-in-a-lifetime event will feature performances by comics Eric Andre and Reggie Watts, followed by a full set of music…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441